Asahi Kasei Therapeutics Corp - Company Profile
Powered by 
All the sales intelligence you need on Asahi Kasei Therapeutics Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Asahi Kasei Therapeutics Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Asahi Kasei Therapeutics Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Asahi Kasei Therapeutics Corp (Asahi Kasei Therapeutics), a subsidiary of Asahi Kasei Corp, is a research-based healthcare company that discovers, develops, manufactures, and markets prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. It offers a wide range of specialty pharmaceuticals for various therapeutic areas. The company's portfolio includes prescription drugs and diagnostic products.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Asahi Kasei Therapeutics is actively engaged in research and development to provide new drugs needed by society, focusing on autoimmune and musculoskeletal fields, including pain. The company aims to address unmet medical needs of aging populations and strives to become a research and development-focused specialty pharmaceutical company by promoting open innovation. The company has developed drugs like Teribone for osteoporosis and Recomodulin for disseminated intravascular coagulation, and is involved in the discovery of therapeutic agents with new mechanisms of action. The Pharmaceuticals Research Center in Izunokuni City, Shizuoka Prefecture, serves as the R&D unit for Asahi Kasei Therapeutics. This center consolidates the synthetic chemistry research division and pharmacological research division, enhancing drug discovery research functionality and creating a globally competitive research environment. The Laboratory for Drug Discovery within this center focuses on strengthening cooperation and exchange between researchers to improve research efficiency and enhance drug discovery. The company has several pipeline products in various development stages, including TA799 (apraglutide), ART-123 (recombinant thrombomodulin alfa), AK1830, AK1910, and AK1960. The company has licensed products from Ironwood Pharmaceuticals, Inc., Array BioPharma Inc. (a subsidiary of Pfizer, Inc.), SBI Biotech Co., Ltd., and Alchemedicine, Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer